HIN Sang Group
HIN Sang Group (HKEX:6893) develops, manufactures, and distributes children's healthcare products, Chinese medicines, nutritional supplements, and skincare under its Hin Sang and Beautymate brands, plus OEM/ODM services, across Greater China and Southeast Asia.
- Company typePublic
- Founded1996
- HeadquartersKowloon City, Hong Kong SAR China
- Headcount101–250
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What HIN Sang Group does
HIN Sang Group (International) Holding Co. Ltd. (HKEX:6893) is a Cayman Islands-incorporated holding company founded in 1996 by Pang Siu Hin and Kwan Lai Man, listed on the Hong Kong Stock Exchange in September 2014. The group operates a vertically integrated branded health products business focused on children's healthcare, Chinese medicines, nutritional supplements, adult health products, and skincare, organized around two core brands — Hin Sang (launched 2004, 15 consecutive years as No.1 Brand for Children's Vitamins and Dietary Supplements in Hong Kong) and Beautymate (skincare, launched 2009). Its flagship proprietary Chinese medicine, Febrifuge (Granules), is the only young child-specific proprietary Chinese medicine in granule form registered with the Hong Kong Department of Health.
The group's manufacturing is anchored by the Hin Sang Health Medical Industrial Park in Yunfu City, Guangdong Province, which obtained Food and Food Additive Production License SC Certification and operates multiple fully automatic production and packaging lines under GMP standards, serving both own-brand production and OEM/ODM contract manufacturing for beverages, convenience foods, and confectionery. Revenue is generated through (a) own-brand product sales across retail chains (Manning's, Watson's, CRCare), pharmacies, e-commerce platforms (including Suning in mainland China), and proprietary Pengzu Hin Sang Pavilion chain stores in the PRC established via a 2021 joint venture with Hongli Homologous Biotechnology; and (b) OEM/ODM manufacturing services. Geographic distribution spans Mainland China, Hong Kong, Macau, Taiwan, and Southeast Asia. FY2025/26 revenue was HK$104.6 million (+13.8% YoY) with a 60.9% gross margin but a net loss of HK$45.5 million, and the company is pursuing property disposals (HK$183M aggregate indicative value) to deleverage while navigating an April 2026 leadership transition triggered by the founder/CEO's criminal custody in the PRC.
HIN Sang Group firmographics
Firmographics- Name
- HIN Sang Group
- Legal name
- Hin Sang Group (International) Holding Co. Ltd.
- Website
- https://hinsanggroup.com
- Company type
- Public
- Founded year
- 1996
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- HIN Sang Group (HKEX:6893) develops, manufactures, and distributes children's healthcare products, Chinese medicines, nutritional supplements, and skincare under its Hin Sang and Beautymate brands, plus OEM/ODM services, across Greater China and Southeast Asia.
- Ownership category
- akta.pro rank
HIN Sang Group industry classification
Industry- Product category
- Children's Healthcare and Nutritional Supplements
- NAICS
- Health and Personal Care Retailers (456)
- SIC
- Perfumes, Cosmetics & Other Toilet Preparations (2844), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Children’s Vitamins & Supplements (CRADAGAJ)
- akta.pro secondary industry
- Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD)
Keywords
Where HIN Sang Group is headquartered
LocationHeadquarters
- HQ city
- Kowloon City
- HQ country
- Hong Kong SAR China
- HQ region
- Asia
Offices2 records
Markets served
HIN Sang Group business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales
Revenue model
- Own Brand Product Sales: The company generates revenue primarily through the sale of its own brand health supplements, infant vitamins, nutritional supplements, adult health products, Chinese medicines, personal care, and skincare products. Revenue for FY2025/26 was HK$104.6 million with gross profit of HK$63.8 million.
- OEM/ODM Manufacturing Services: The company provides Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM) manufacturing services, producing beverages, convenience foods, and confectionery products that meet GMP requirements for external brands and clients.
- Property Disposal: The company is in the process of potentially disposing of properties (Shatin property with carpark at indicative asking price of HK$138 million and Tsim Sha Tsui property at HK$45 million) to realize cash and reduce bank borrowings.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Hin Sang Febrifuge (Granules) - proprietary Chinese medicine for young children |
| Unit Pricing | Pay-as-you-go | Beautymate Acne Repairing Serum - skincare product |
Go-to-market motion2 records
Distribution channels6 records
Marketing channels5 records
HIN Sang Group product offering
Product offeringCore offering
Hin Sang Group manufactures and sells children's healthcare products (infant vitamins, nutritional supplements, and adult health products) under the flagship Hin Sang brand, personal care and skincare products under the Beautymate brand, and proprietary Chinese medicines (including the Febrifuge Granules). In addition, the group provides OEM and ODM manufacturing services for external brand owners producing beverages, convenience foods, and confectionery products that meet GMP requirements, operated from its Hin Sang Health Medical Industrial Park in Yunfu City, Guangdong Province.
Product overview
HIN Sang Group is a brand management and manufacturing company primarily engaged in children's healthcare, Chinese medicines, and traditional Chinese medical related projects. The company's core offering is the 'Hin Sang' flagship brand product series (infant vitamins, nutritional supplements, adult health products), which is supplemented by the 'Beautymate' skincare sub-brand. The group operates its own manufacturing through the Hin Sang Health Medical Industrial Park in Guangdong Province and provides OEM/ODM manufacturing services to third parties. Products are distributed across Mainland China, Hong Kong, Macau, Taiwan, and Southeast Asia. The company was founded in 1996 and has been certified as the No.1 Brand for Children's Vitamins and Dietary Supplements in Hong Kong for 15 consecutive years.
Differentiator
Problem solved
Functional benefit
Brands
- Beautymate: Skincare brand launched in 2009, known for products such as Acne Repairing Serum
- Hin Sang
Products and services
- Hin Sang Series Flagship own-brand product line combining traditional herbal ingredients and advanced technology. Includes infant vitamins, nutritional supplements, and adult health products. Certified as No.1 Brand for Children's Vitamins and Dietary Supplements in Hong Kong for 15 consecutive years. Targeted at parents, caregivers, and adult consumers across Hong Kong, Mainland China, Macau, Taiwan, and Southeast Asia.
- Febrifuge (Granules) Proprietary Chinese medicine in granule form for young children to relieve fever, fight influenza virus, and boost immune systems. The only young child-specific proprietary Chinese medicine in granule form in Hong Kong, registered with and approved by the Department of Health. HKC certificate accredited. Suggested retail price HK$68.9 per package.
- Beautymate (skincare brand) Skincare brand launched in 2009, featuring products such as Acne Repairing Serum. Has become one of the company's best-selling brands in Asia. Distributed through Manning's and Watson's stores and pharmacies across Hong Kong.
- Beautymate Acne Repairing Serum Skincare product under the Beautymate brand designed to address acne concerns. Sold at Manning's and Watson's stores and pharmacies across Hong Kong at a suggested retail price of HK$59.9 per unit.
- OEM/ODM Manufacturing Services Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM) services covering beverages, convenience foods, and confectionery products that meet GMP requirements. Produced at the Hin Sang Health Medical Industrial Park in Yunfu City, Guangdong Province, with SC Certification. Targeted at external brand owners and product companies needing contract manufacturing capacity.
- Aerospace Antivirus King and Bens Sterilizer (sole distributorship) Sterilization and antivirus products distributed under sole distributorship rights for Hong Kong and Macau markets.
Quantifiable outcome
- HK$104.6 million revenue in FY2025/26, up 13.8% year-over-year
- +2 more outcomes
Companies that use HIN Sang Group
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles3 records
HIN Sang Group technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
HIN Sang Group partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Hongli Homologous Biotechnology (Weihai) Company Limited (紅力同源生物科技(威海)有限公司)coreOn 29 December 2021, Hin Sang Health and Medical (Guangdong) Company Limited (衍生健康醫藥(廣東)有限公司), a wholly-owned subsidiary of the company, entered into a cooperation agreement with Hongli Homologous Biotechnology (Weihai) Company Limited to establish Pengzu Hin Sang Pavilion (Guangdong) Brand Management Company Limited (彭祖衍生館(廣東)品牌管理有限公司). The new brand management company opens chain stores in the name of 'Pengzu Hin Sang Pavilion' (彭祖衍生館) in the PRC, exclusively selling products supplied by Hin Sang Guangdong.
- Fullshare Holdings Limited (Stock code: 607)coreOn 27 April 2016, the company entered into a joint venture agreement with Fullshare Holdings Limited for the development of mother and child health products, pharmaceutical factory, hospital, medical centre and related services. The company subscribed for 306,000,000 JV Shares for HK$30,600,000 (51% of JV Company), while Fullshare subscribed for 294,000,000 JV Shares for HK$29,400,000 (49%). The company also provided a Shareholder's Loan of not less than HK$69,400,000 to the JV Company. Fullshare Holdings is a substantial shareholder of the company. Ms. Tian Shanshan, a non-executive director, serves as president assistant of Fullshare Holdings.
Scale indicators10 records
Recent moves7 records
Expansion highlights6 records
HIN Sang Group competitors and assessment
Company assessmentBroad incumbents
- BYHEALTH Co., Ltd. (300146.SZ): China's largest nutritional supplement manufacturer offering vitamins and supplements including children's health products. Comparable in product category (vitamins, supplements) with broadly overlapping target demographics.
- China Traditional Chinese Medicine Holdings Limited (570.HK): Large-scale Chinese medicine manufacturer controlled by Sinopharm Group, covering the full TCM value chain from cultivation to retail. Comparable as a regulated Chinese medicine player with manufacturing and distribution; broader in scale than Hin Sang.
- Infinitus International Company Limited: China-based direct-selling and consumer health products company owned by LKK Health Products Group, focused on Chinese herbal health supplements and personal care. Comparable in TCM-based health products and own-brand distribution model.
Direct peers
- Purapharm Corporation Limited (formerly listed 8158.HK): Hong Kong-headquartered traditional Chinese medicine company with branded TCM products and Chinese medicine granules. Comparable product portfolio (proprietary Chinese medicine granules) and HK distribution focus.
- Vita Green Pharmaceutical (Holdings) Limited: Hong Kong-based health supplement and Chinese medicine manufacturer with own brands focused on adult and child health products. Highly comparable as a HK-domiciled CPG health supplements brand using Chinese medicine heritage.
- Green Cross Healthcare Group Limited: Hong Kong-based health and personal care retailer/distributor operating pharmacy chains and health product distribution. Closely comparable to Hin Sang's pharmacy-led distribution of healthcare products and Chinese medicines across Hong Kong.
- Beijing Tong Ren Tang Chinese Medicine Co. Ltd. (1666.HK): Hong Kong-listed Chinese medicine company with retail chain distribution and proprietary Chinese medicine products. Comparable in product category (proprietary Chinese medicine) and pharmacy-led retail distribution model.
Emerging players
- Swisse Wellness Pty Ltd (H&H Group, 1112.HK): Premium Australian vitamins and supplements brand owned by H&H Group (Biostime), heavily distributed in China and Asia through cross-border and pharmacy channels. Comparable as a vitamins/supplements brand competing for the same Chinese consumer.
- Blackmores Limited (BKL.AX): Asia-Pacific premium vitamins and supplements brand expanding into China and Southeast Asia. Comparable as a brand-led vitamins/supplements specialist with growing Asia presence; competes in the same end-markets as Hin Sang.
Regional players
- Hengan International Group Company Limited (1044.HK): Hong Kong-listed consumer products company specializing in personal care (tissue, sanitary, skin care) and sold through similar retail pharmacy channels in Greater China. Comparable in personal care product line and Mandarin-speaking market distribution.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights7 records
Customer concentration
HIN Sang Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
HIN Sang Group leadership team
Management profileNumber of profiles
Profiles7 records
HIN Sang Group subsidiaries and ownership
Company hierarchySubsidiaries1 record
HIN Sang Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
HIN Sang Group M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about HIN Sang Group
What does HIN Sang Group do?
Hin Sang Group manufactures and sells children's healthcare products (infant vitamins, nutritional supplements, and adult health products) under the flagship Hin Sang brand, personal care and skincare products under the Beautymate brand, and proprietary Chinese medicines (including the Febrifuge Granules). In addition, the group provides OEM and ODM manufacturing services for external brand owners producing beverages, convenience foods, and confectionery products that meet GMP requirements, operated from its Hin Sang Health Medical Industrial Park in Yunfu City, Guangdong Province.
Is HIN Sang Group a public or private company?
HIN Sang Group is a public company. It is classified as public and is currently operating.
When was HIN Sang Group founded?
HIN Sang Group was founded in 1996. It employs 101 to 250 people.
Where is HIN Sang Group based?
HIN Sang Group is headquartered in Kowloon City, Hong Kong SAR China, in the Asia region.
How does HIN Sang Group make money?
Three revenue lines are on record. Own Brand Product Sales are the primary driver. The others are OEM/ODM Manufacturing Services and property Disposal.
Who are HIN Sang Group's main competitors?
Broad incumbents on record are BYHEALTH Co., Ltd. (300146.SZ), China Traditional Chinese Medicine Holdings Limited (570.HK) and Infinitus International Company Limited. Direct peers are Purapharm Corporation Limited (formerly listed 8158.HK), Vita Green Pharmaceutical (Holdings) Limited, Green Cross Healthcare Group Limited and Beijing Tong Ren Tang Chinese Medicine Co. Ltd. (1666.HK). Emerging players are Swisse Wellness Pty Ltd (H&H Group, 1112.HK) and Blackmores Limited (BKL.AX). Hengan International Group Company Limited (1044.HK) is listed as a regional player.
Does HIN Sang Group have an API?
No public API is recorded for HIN Sang Group.
What industry is HIN Sang Group in?
HIN Sang Group's product category is Children's Healthcare and Nutritional Supplements. Its primary akta.pro industry code is CRADAGAJ, Children’s Vitamins & Supplements, with a secondary code of CRADAMAD, Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges). Its NAICS code is 456 and its SIC code is 2844.